APPLICATIONS PUBLISHED 15 MAY 2002

Published: 1-Dec-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Pharmaceutical gel formulation
    Nowakowski, Grzegorz 1204314*

  • hybrid ionic phosphorus surfactant adjuvants for bioactive compsns
    Rhodia 1204315*

  • Sulphur adsorbent for reducing onion or garlic breath odour
    PQ Holding 1204402*

  • Compsn for topical administration comprising 5-methoxypsoralen
    Goupil, Jean-Jacques 1204404*

  • Skin cleansing compsn with improved stability
    Colgate-Palmolive 1204405*

  • Opioid sustained-release formulation
    Roxane Laboratories 1202406*

  • Implantable active ingredient depot
    Max-Delbrueck-Centrum fuer Molekulare Medizin 1204407*

  • An improved form of form I celiprolol hydrochloride
    Ranbaxy Laboratories 1204408*

  • Microparticles for pulmonary administration
    Mainelab 1204409*

  • Multi-component pharmaceutical dosage form
    SmithKline Beecham 1204410*

  • Apicidin-derived cyclic tetrapeptides
    Merck 1204411*

  • Use of Etodolac to treat cancer
    The Regents of the University of California 1204412*

  • Use of morphinan derivatives as medicaments
    Gruenenthal 1204414*

  • 5-(E)-bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
    Yale University 1204415*

  • Carnitine analogues as topical, microbicidal spermicides
    Virginia Tech Intellectual Properties 1204416*

  • Parenteral cisplatin emulsion
    Daftary, Gautan Vinod 1204417*

  • Compsn containing muscle-derived active agents
    Can-Fite Biopharma 1204418*

  • Inhibitors of the lectin complement pathway (lcp) and their use
    The Brigham and Women's

    Hospital 1204419*

  • Trehalose producing prokaryotic cells as vaccines
    Immunobiology 1204420*

  • Stress protein-peptide complexes as vaccines against intra-cellular pathogens
    Immunobiology 1204421*

  • Stress-proteins from extra-cellular pathogens as vaccines against infectious agents
    Immunobiology 1204422*

  • Therapeutic antibody against muco-antigen and methods for their use
    Altarex 1204423*

  • Recombinant RSV virus expression systems and vaccines
    Aviron 1204424*

  • Methods of modulating an immune response using immunostimulatory sequences and compsns for use therein
    Dynavax Technologies Corp 1204425*

  • Medical preparation for treating arthrosis, arthritis and other rheumatic joint disorders
    Magforce Applications 1204426*

  • The nasal transmucosal delivery of peptides conjugated with biocompatible polymers
    Park, Myung-Ok; Lee, Kang Choon 1204427*

  • Targeted lipid particles
    Celltech R&D 1204428*

  • Sustained release formulation of a peptide
    Societe de Conseils de Recherches et d'Applications Scientifiques 1204429*

  • Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
    Aventis Pharma 1204430*

  • Method for producing 1-methyl-3-nitroguanidine
    Nigu Chemie 1204633*

  • Branched, substantially unsaturated alcohol sulfates
    Cognis Deutschland 1204634*

  • 3-oxopropane-1-sulphonic acids and sulphonates
    DSM 1204636*

  • Process for the preparation of isotretinoin
    Ranbaxy Laboratories 1204637*

  • Synthesis of a novel paramagnetic amino acid derivative (EPM-5) for labelling chemical and biological macromolecules
    Conselho Nacional de Desenvolvimento Cientifico e Technologico 1204639*

  • Chemokine receptor antagonists and methods of use therefor
    Millennium Pharmaceuticals 1204640*

  • 4-aminopiperidine derivatives of tetrahydronapthalene, chromans and thiochromans
    AstraZeneca 1204641*

  • Fungicides
    Aventis CropScience 1204642*

  • Fungicidal heterocyclic aromatic amides and their compsns, methods of use and preparation
    Dow AgroScience 1204643*

  • Synthesis of substituted amidines
    Eli Lilly 1204644*

  • Melanocortin-4 receptor binding compounds and methods of use thereof
    Millennium Pharmaceuticals 1204645*

  • 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor
    Aventis Pharma Deutschland 1204646*

  • Method for the production of 4-6-dichloropyrimidine with the aid of phosgene
    Bayer 1204647*

  • Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumour agents
    Pharmacia Italia 1204649*

  • Substituted 2-arylbenzazole compounds and their use as antitumour agents
    Cancer Research Ventures 1204650*

  • Novel succinate derivative compounds useful as cysteine protease inhibitors
    Boehringer Ingelheim Pharmaceuticals 1204652*

  • Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists
    Eli Lilly 1204654*

  • A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[B]-thiophene hydrochloride
    Eli Lilly 1204655*

  • Piperidine and pyrrolidine derivatives displaying neuronal activity
    Schering; Vertex Pharmaceuticals 1204657*

  • You may also like